Transgenic Group Inc.

TSE:2342 Stock Report

Market Cap: JP¥2.8b

Transgenic Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Kenji Fukunaga

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure14.5yrs
CEO ownership1.1%
Management average tenureno data
Board average tenure5.5yrs

Recent management updates

Recent updates

Transgenic Group Inc.'s (TSE:2342) Share Price Is Matching Sentiment Around Its Revenues

Nov 13
Transgenic Group Inc.'s (TSE:2342) Share Price Is Matching Sentiment Around Its Revenues

Improved Revenues Required Before Trans Genic Inc. (TSE:2342) Shares Find Their Feet

Apr 27
Improved Revenues Required Before Trans Genic Inc. (TSE:2342) Shares Find Their Feet

CEO

Kenji Fukunaga (55 yo)

14.5yrs

Tenure

Kenji Fukunaga has been the President of Transgenic Group Inc. (formerly known as Trans Genic Inc.) since June 2010. Kenji Fukunaga serves as the Chief Executive Officer at Trans Genic Inc and had been its...

Board Members

NamePositionTenureCompensationOwnership
Kenji Fukunaga
CEO, President & Representative Director15.5yrsno data1.1%
¥ 30.6m
Kazuo Watanabe
GM of Accounting & Finance Department and Director6.5yrsno data0.12%
¥ 3.4m
Yutaka Funabashi
GM of IR13.5yrsno data0.19%
¥ 5.2m
Shunichi Kitajima
Head of CRO Business Divisionno datano data0.18%
¥ 5.0m
Takao Sato
Outside Audit & Supervisory Board Member16.5yrsno datano data
Tsutomu Seito
Independent Outside Director13.5yrsno datano data
Masafumi Honbou
Outside Audit & Supervisory Board Member4.5yrsno data0.090%
¥ 2.5m
Ryoji Tomonaga
Audit & Supervisory Board Member4.5yrsno datano data
Hotaka Saito
Independent Outside Director3.5yrsno datano data
Koji Takashima
Directorless than a yearno datano data
Akihito Tomita
Directorless than a yearno data0.060%
¥ 1.7m

5.5yrs

Average Tenure

64yo

Average Age

Experienced Board: 2342's board of directors are considered experienced (5.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 11:13
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Transgenic Group Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pravin GondhaleVirtua Research Inc.